Tuesday, September 20, 2016

HFSA: Treat to NT-proBNP Target Flops in Trial

(MedPage Today) -- Outcomes no better with treatment aimed at 30% reduction
via HFSA: Treat to NT-proBNP Target Flops in Trial
by
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)